EXCLI Journal 2018;17:169-180 – ISSN 1611-2156
Received: October 17, 2017, accepted: January 29, 2017, published: February 01, 2018
Nasr T, Bondock S, Eid S. Design, synthesis, antimi-
crobial evaluation and molecular docking studies of
some new 2, 3-dihydrothiazoles and 4-thiazolidinones
containing sulfisoxazole. J Enzyme Inhib Med Chem.
2016;31:236-46.
Conflict of interest
The authors declare that they have no
conflict of interest.
REFERENCES
Randall CP, Mariner KR, Chopra I, O’Neill AJ. The
target of daptomycin is absent from Escherichia coli
and other Gram-negative pathogens. Antimicrob
Agents Chemother. 2013;57:637–9.
Achari A, Somers DO, Champness JN, Bryant PK,
Rosemond J, Stammers DK. Crystal structure of the
anti-bacterial sulfonamide drug target dihydropteroate
synthase. Nat Struct Biol. 1997;4:490-7.
Sauton N, Lagorce D, Villoutreix BO, Miteva MA.
MS-DOCK: accurate multiple conformation generator
and rigid docking protocol for multi-step virtual lig-
and screening. BMC Bioinformatics. 2008;9:184.
Argyropoulou I, Geronikaki A, Vicini P, Zani F. Syn-
thesis and biological evaluation of sulfonamide thia-
zole and benzothiazole derivatives as antimicrobial
agents. Arkivoc. 2009;6:89-102.
Sengupta S, Chattopadhyay MK, Grossart H-P. The
multifaceted roles of antibiotics and antibiotic re-
sistance in nature. Front Microbiol. 2013;4:47.
Bano S, Javed K, Ahmad S, Rathish I, Singh S, Alam
M. Synthesis and biological evaluation of some new
2-pyrazolines bearing benzene sulfonamide moiety as
potential anti-inflammatory and anti-cancer agents.
and XII. Eur J Med Chem. 2011;46:5763-8.
Seydel JK. Sulfonamides, structure-activity relation-
ship, and mode of action. Structural problems of the
antibacterial action of 4-aminobenzoic acid (PABA)
antagonists. J Pharm Sci. 1968;57:1455-78.
Ezabadi IR, Camoutsis C, Zoumpoulakis P, Geroni-
kaki A, Soković M, Glamočilija J, et al. Sulfonamide-
1, 2, 4-triazole derivatives as antifungal and antibacte-
rial agents: Synthesis, biological evaluation, lipo-
philicity, and conformational studies. Bioorg Med
Chem. 2008; 16:1150-61.
Sköld O. Sulfonamide resistance: mechanisms and
trends. Drug Resistance Updates. 2000;3:155-60.
Sławiński J, Szafrański K, Vullo D, Supuran CT.
Carbonic anhydrase inhibitors. Synthesis of heterocy-
clic 4-substituted pyridine-3-sulfonamide derivatives
and their inhibition of the human cytosolic isozymes I
and II and transmembrane tumor-associated isozymes
IX and XII. Eur J Med Chem. 2013;69:701-10.
Kamel MM, Ali HI, Anwar MM, Mohamed NA, So-
liman AM. Synthesis, antitumor activity and molecu-
lar docking study of novel sulfonamide-Schiff's bases,
thiazolidinones, benzothiazinones and their C-
nucleoside derivatives. Eur J Med Chem. 2010;45:
572-80.
Zoumpoulakis P, Camoutsis C, Pairas G, Soković M,
Glamočlija J, Potamitis C, et al. Synthesis of novel
sulfonamide-1, 2, 4-triazoles, 1, 3, 4-thiadiazoles and
1, 3, 4-oxadiazoles, as potential antibacterial and anti-
fungal agents. Biological evaluation and conforma-
tional analysis studies. Bioorg Med Chem. 2012;20:
1569-83.
Lushniak BD. Antibiotic resistance: a public health
crisis. Public Health Rep. 2014;129:314-6.
Lengauer T, Rarey M. Computational methods for bi-
omolecular docking. Curr Opin Struct Biol. 1996;6:
402-6.
Mondal S, Mandal SM, Mondal TK, Sinha C. Struc-
tural characterization of new Schiff bases of sulfa-
methoxazole and sulfathiazole, their antibacterial ac-
tivity and docking computation with DHPS protein
structure. Spectrochim Acta A. 2015;150:268-79.
180